Clinical Trial Research
Next Pharmaceuticals Discloses Results of Nexrutine(R) Clinical Study
Published in Healthcare Finance, Tax and Law Weekly, December 12th, 2007
Next Pharmaceuticals announced the results of a clinical study on Nexrutine, conducted at The LaValle Metabolic Institute in Cincinnati, Ohio. Nexrutine is a proprietary blend of natural ingredients developed to address general aches and pains associated with physical activity and over-exertion. Out of the 401 participants 369 (92%) reported Nexrutine provided pain relief and 373 (93%) reported improvement in their overall condition. Three hundred sixty one (90%) reported Nexrutine helped provide a restful sleep.
The study concluded that Nexrutine, when used as a dietary supplement, helps in the management of pain and/or inflammation and helps promote a restful sleep...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- Addiction Medicine
New addiction medicine data have been reported by D.A. Highfield and co-authors - Adverse Drug Reactions
Vermont Requires Reporting of NQF Serious Reportable Events - Aging
Global Health and Global Aging Presents Information about Leadership and Governance Challenges as Well as Insights about Aging in Different Cultures and Countries in All Regions of the World - Alcoholism
Both alcohol dependence and conduct disorder contribute to having a high number of sex partners - Alexian Brothers Hospital Network
New Study Shows More Than Half of All Americans are Unable to Access Vital Records Quickly During an Emergency - Alliance Imaging, Inc.
Alliance Imaging Announces Proposed Private Offering of $125 Million of Senior Subordinated Notes - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
